4587 PeptiDream Inc. - Financial Results

About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.

4587

TSE Prime

PeptiDream Inc.

1,563.0

JPY

+12.0

(+0.77%)

Dec 5, 12:57 pm JST

10.07

USD

Dec 4, 10:57 pm EST

Result

PTS

outside of trading hours

1,563

Dec 5, 12:56 pm JST

Summary Chart Historical News Financial Result

Current Period Guidance

Annual

Result

Guidance History

Growth Rate

Profitability

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Dec, 2021	9,365	4,418	4,774	3,606	28.0	0	Feb 9, 2022	J-GAAP
Dec, 2022	26,852	8,980	6,653	7,554	58.2	0	Feb 14, 2023	IFRS
Dec, 2023	28,712	6,773	4,353	3,035	23.4	0	Feb 14, 2024	IFRS
Dec, 2024	46,676	21,113	20,888	15,014	115.9	0	Feb 13, 2025	IFRS
Dec, 2025 Guidance	18,000	-5,400	-5,800	-4,000	-31.0	0	Dec 2, 2025	IFRS
YoY	-61.4%	－	－	－	－

Revision Direction	Revision Date	Revenue	Operating Profit	Ordinary Profit	Net Profit	Revised Dividend	Accounting Standards
Dec, 2020	Feb 13, 2020	10,000	5,300	5,400	4,000	0	J-GAAP
	Jan 4, 2021	11,600	6,700	6,700	4,200	0	J-GAAP
Results	Feb 10, 2021	11,677	6,991	6,976	4,448	0	J-GAAP
Dec, 2021	Feb 10, 2021	Available in future release
	Dec 22, 2021
Results	Feb 9, 2022
Dec, 2022	Feb 9, 2022
	May 12, 2022
	Nov 10, 2022
	Jan 18, 2023
Results	Feb 14, 2023
Dec, 2023	Feb 14, 2023
Results	Feb 14, 2024
Dec, 2024	Feb 14, 2024
	May 14, 2024
Results	Feb 13, 2025
Dec, 2025	Feb 13, 2025	49,000	21,600	21,200	15,100	0	IFRS
	Dec 2, 2025	18,000	-5,400	-5,800	-4,000	0	IFRS

Fiscal Year	Revenue	YoY	Operating Profit	YoY	Ordinary Profit	YoY	Adj. EPS	YoY
Jun, 2008	60	－	Available in future release
Jun, 2009	86	+43.3
Jun, 2010	91	+5.8
Jun, 2011	601	+560.4
Jun, 2012	269	-55.2
Jun, 2013	678	+152.0
Jun, 2014	818	+20.6
Jun, 2015	2,474	+202.4
Jun, 2016	4,327	+74.9
Jun, 2017	4,895	+13.1
Jun, 2018	6,426	+31.3
Jun, 2019	7,216	+12.3
Dec, 2019 Changed	1,037	－
Dec, 2020	11,677	+1,026.0
Dec, 2021	9,365	-19.8
Dec, 2022	26,852	+186.7
Dec, 2023	28,712	+6.9
Dec, 2024	46,676	+62.6
Dec, 2025 Guidance	18,000	-61.4	-5,400	－	-5,800	－	-31.0	－

Fiscal Year	Revenue	Operating Profit	Operating Profit Margin	ROE	ROA	Total Asset Turnover Ratio	Adj. EPS
Dec, 2023	28,712	6,773	23.6	8.39	4.55	0.43	23.4
Dec, 2024	46,676	21,113	45.2	30.92	18.51	0.58	115.9
Dec, 2025 Guidance	18,000	-5,400	-30	-7.61	-5.16	0.23	-31.0

All-Time High

	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS
Record	46,676	21,113	20,888	15,014	115.9
Fiscal Year	Dec, 2024	Dec, 2024	Dec, 2024	Dec, 2024	Dec, 2024

Second Half

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Jul - Dec, 2022	21,828	10,645	8,243	8,686	66.9	0	Feb 14, 2023	IFRS
Jul - Dec, 2023	19,286	7,759	5,463	3,764	29.0	0	Feb 14, 2024	IFRS
Jul - Dec, 2024	10,543	-3,536	-3,854	-2,911	-22.5	0	Feb 13, 2025	IFRS
Jul - Dec, 2025 Guidance	9,457	-2,775	-2,938	-1,878	-14.5	0	Dec 2, 2025	IFRS
YoY	-10.3%	+21.5%	+23.8%	+35.5%	+35.3%

Cash Flow

Annual

Fiscal Year	Operating Profit	Fee Cash Flow	Operating Cash Flow	Investing Cash Flow	Financial Cash Flow	Cash & Equivalents	Cash Ratio	Accounting Standards
Dec, 2022	8,980	-27,459	-82	-27,377	20,789	5,247	8.22	IFRS
Dec, 2023	6,773	13,722	12,420	1,302	264	19,507	28.08	IFRS
Dec, 2024	21,113	32,214	23,844	8,370	-2,994	48,117	51.87	IFRS

Actual Performance and Financial Trends

Accumulated Results 3rd Quarter

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Progress Rate vs. First Half	Announce	Accounting Standards
Jan - Sep, 2023	22,543	6,752	4,661	3,541	27.3	107.1	Nov 9, 2023	IFRS
Jan - Sep, 2024	41,604	24,522	24,300	17,620	136.0	116.3	Nov 13, 2024	IFRS
Jan - Sep, 2025	12,857	-4,058	-4,339	-3,217	-24.9	ー	Nov 12, 2025	IFRS
YoY	-69.1%	－	－	－	－

Quarterly Results

Result

Growth Rate

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Operating Profit Margin	Announce	Accounting Standards
Oct - Dec, 2023	6,169	21	-308	-506	-3.9	0.3	Feb 14, 2024	IFRS
Jan - Mar, 2024	4,225	-1,098	-1,104	-842	-6.5	-26.0	May 14, 2024	IFRS
Apr - Jun, 2024	31,908	25,747	25,846	18,767	144.8	80.7	Aug 8, 2024	IFRS
Jul - Sep, 2024	5,471	-127	-442	-305	-2.4	-2.3	Nov 13, 2024	IFRS
Oct - Dec, 2024	5,072	-3,409	-3,412	-2,606	-20.1	-67.2	Feb 13, 2025	IFRS
Jan - Mar, 2025	4,233	-1,367	-1,433	-1,033	-8.0	-32.3	May 13, 2025	IFRS
Apr - Jun, 2025	4,310	-1,258	-1,429	-1,089	-8.4	-29.2	Aug 6, 2025	IFRS
Jul - Sep, 2025	4,314	-1,433	-1,477	-1,095	-8.5	-33.2	Nov 12, 2025	IFRS
YoY	-21.1%	-1,028.3%	-234.2%	-259.0%	-260.4%

Fiscal Year	Revenue	YoY	Operating Profit	YoY	Ordinary Profit	YoY	Adj. EPS	YoY
Oct - Dec, 2020	7,845	－	Available in future release
Jan - Mar, 2021	1,459	+271.2
Apr - Jun, 2021	1,420	-47.7
Jul - Sep, 2021	4,884	+573.7
Oct - Dec, 2021	1,602	-79.6
Jan - Mar, 2022	419	-71.3
Apr - Jun, 2022	4,605	+224.3
Jul - Sep, 2022	6,184	+26.6
Oct - Dec, 2022	15,644	+876.5
Jan - Mar, 2023	4,963	+1,084.5
Apr - Jun, 2023	4,463	-3.1
Jul - Sep, 2023	13,117	+112.1
Oct - Dec, 2023	6,169	-60.6
Jan - Mar, 2024	4,225	-14.9
Apr - Jun, 2024	31,908	+614.9
Jul - Sep, 2024	5,471	-58.3
Oct - Dec, 2024	5,072	-17.8
Jan - Mar, 2025	4,233	+0.2
Apr - Jun, 2025	4,310	-86.5
Jul - Sep, 2025	4,314	-21.1	-1,433	-1,028.3	-1,477	-234.2	-8.5	-254.2

All-Time High Quarterly Results

	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS
Record	31,908	25,747	25,846	18,767	144.8
Fiscal Year	Jun, 2024	Jun, 2024	Jun, 2024	Jun, 2024	Jun, 2024

Key Balance Sheet Figures

Fiscal Year	BPS	Equity Ratio	Total Asset	Equity	Retained Earnings	Interest-Bearing Debt Ratio	Announce	Accounting Standards
Dec, 2022	246.63	50.2	63,865	32,041	23,848	0.66	Feb 14, 2023	IFRS
Dec, 2023	311.16	58.1	69,464	40,349	27,804	0.55	Feb 14, 2024	IFRS
Dec, 2024	437.63	61.2	92,769	56,762	49,393	0.35	Feb 13, 2025	IFRS
Jan - Sep, 2025	ー	67.8	77,573	52,596	46,176	0.34	Nov 12, 2025	IFRS

PeptiDream Inc.(4587) Financial Results